Andrew Huberman, a neuroscience professor at Stanford, has stated publicly that "BPC-157 is one of the more interesting peptides because of the gastric juice origin and the acid stability, but the lack of human trials is a real limitation that people tend to overlook." This sentiment reflects the tension between preclinical promise and clinical evidence gaps
Can I take epitalon with other peptides
Thankfully, they named it appropriately this time
Who Should Be Cautious About Using Healing Peptides Alone A conservative approach matters most in these groups: People with unclear diagnosis (pain without a clear tissue source) Those with systemic inflammatory conditions and frequent flares Individuals on complex medication regimens where interactions and contraindications matter People with a history of malignancy who need careful risk framing Anyone seeking a passive fix while ignoring rehabilitation and lifestyle structure Cautious does not mean never. It means the bar for oversight, sequencing, and monitoring should be higher
A 2011 mechanism paper by Chang and colleagues in Journal of Applied Physiology demonstrated that BPC-157 promotes tendon fibroblast outgrowth, supports fibroblast survival under oxidative stress, and facilitates cell migration through the FAK-paxillin signaling pathway a pathway central to cell adhesion and movement
PubMed Central , Biological Chemistry , vol
